BCOS
@BCOSCardioOnc
Our mission is to promote research, best clinical practice and a wider understanding of the effects of cancer treatment on the cardiovascular system.
213 Following 518 Followers 173 Posts
Latest posts 5
Food for thought. Are the historical anthracycline conversion ratios still appropriate for use in contemporary clinical practice and research?
jamanetwork.com/journals/jamao…
jamanetwork.com/journals/jamao…
jamanetwork.com Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset... This multicenter cohort study pools data from more than 28 000 children with cancer who had survived 5 or more years to evaluate the optimal dose equivalence ratio for late-onset cardiomyopathy... A selection of the 10 best cardio-oncology papers this year (in no particular order...)🎁🎄🎅 @CircAHA @escardio @ehj_ed @JACCJournals @NatureMedicine @JAMA_current @ICOSociety @CD_AACR @ACPUK @BritSocHaem @TheBHF
Cardiac CARE trial: Multicentre prospective RCT of breast Ca and NHL anthracycline recipients at high risk of cardiotox. High risk defined by cTnI concentration in upper tertile during chemo. @ninianlang @HenriksenDr @ICOSociety
ahajournals.org/doi/10.1161/CI…
ahajournals.org/doi/10.1161/CI…
www.ahajournals.org Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided... BACKGROUND: Anthracycline-induced cardiotoxicity has a variable incidence, and the development of left ventricular dysfunction is preceded by elevations in cardiac troponin concentrations. Beta-adr... Upcoming event from IC-OS focusing on the cardiovascular health of childhood cancer survivors with a keynote address from Steven Lipshultz.
The agenda look excellent, register below if interested:
members.ic-os.org/event/pediatri…
The agenda look excellent, register below if interested:
members.ic-os.org/event/pediatri…